NCT01761565View on ClinicalTrials.gov

Single and Multiple Dose Pharmacokinetics of Sufentanil NanoTab

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Plasma Concentrations
Interventions
DRUG

Single dose of SUF NT 15 mcg

DRUG

40 consecutive doses of SUF NT 15 mcg taken every 20 minutes

Trial Locations (1)

66219

PRA, Lenexa

All Listed Sponsors
lead

Talphera, Inc

INDUSTRY

NCT01761565 - Single and Multiple Dose Pharmacokinetics of Sufentanil NanoTab | Biotech Hunter | Biotech Hunter